Condition
AD-MCI clinical trials and research
As of November 12, 2026, Find a Trial lists 2 AD-MCI clinical trials that are recruiting, at sites in 2 countries (most in China (1), United States (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Temporal Interference Stimulation for cognitive impairment
This study tests a non-invasive brain stimulation method called temporal interference stimulation to see if it can improve thinking and memory in people with mild cognitive impairment, Alzheimer's disease, or frontotemporal dementia.
-
Stem Cells plus monoclonal antibodies for mild cognitive impairment or early Alzheimer's disease
This study tests whether one infusion of human mesenchymal stem cells added to standard antibody therapy can slow cognitive and daily-living decline in people with mild Alzheimer's or mild cognitive impairment who are already on approved antibody treatment.
Related topics
Quick answers
How many AD-MCI clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.